Evidence map›Paper›PMID 21844338›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Protection from UV-induced skin carcinogenesis by genetic inhibition of the ataxia telangiectasia and Rad3-related (ATR) kinase.

Masaoki Kawasumi, Bianca Lemos, James E Bradner, Renee Thibodeau, Yong-son Kim, Miranda Schmidt, Erin Higgins, Sang-wahn Koo, Aimee Angle-Zahn, Adam Chen and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 56 citations in OpenAlex.

  1. Pharmaceuticals (Basel, Switzerland) · 2025
    Review
  2. Article
  3. Phototherapy and DNA Damage: A Systematic Review.The Journal of clinical and aesthetic dermatology · 2023
    Article
  4. Review
  5. The 6-4 photoproduct is the trigger of UV-induced replication blockage and ATR activation.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  6. Review
  7. Article
  8. Article
  9. Targeting ATR in cancer.Nature reviews. Cancer · 2018
    Review
  10. Article
  11. Biomedical Research as a Team Sport.The Journal of investigative dermatology · 2017
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Molecular Pathways: Targeting ATR in Cancer Therapy.Clinical cancer research : an official journal of the American Association for Cancer Research · 2015
    Review
  18. Article
  19. Article
  20. Replication stress and cancer.Nature reviews. Cancer · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Masaoki KawasumiDivision of Dermatology, Department of Medicine, University of Washington, Seattle, WA 98109, USA.
Bianca Lemos
James E Bradner
Renee Thibodeau
Yong-son Kim
Miranda Schmidt
Erin Higgins
Sang-wahn Koo
Aimee Angle-Zahn
Adam Chen
Douglas Levine
Lynh Nguyen
Timothy P Heffernan
Isabel Longo
Anna Mandinova
Yao-Ping Lu
Allan H Conney
Paul Nghiem
Massachusetts General Hospital · USUniversity of Washington · USHarvard University · USRutgers, The State University of New Jersey · USFred Hutch Cancer Center · US

Funding

The replication checkpoint and genomic fidelity in skinR01AR049832 · NIAMS · UNIVERSITY OF WASHINGTON · PI NGHIEM, PAUL · 2003 to 2014
$3.6M
Inhibition of skin cancer by caffeine: Effects on late stages of carcinogenesisR01CA130857 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI LU, YAOPING · 2008 to 2012
$1.4M
Selective Inhibition of HDAC6 in Cancer TherapyK08CA128972 · NCI · DANA-FARBER CANCER INST · PI BRADNER, JAMES E · 2008 to 2012
$789k
NCI NIH HHS K08 CA128972NCI NIH HHS R01 CA130857NCI NIH HHS R01-CA130857NIAMS NIH HHS R01 AR049832NIAMS NIH HHS R01-AR049832
6 · The paper itself

Abstract

Multiple human epidemiologic studies link caffeinated (but not decaffeinated) beverage intake with significant decreases in several types of cancer, including highly prevalent UV-associated skin carcinomas. The mechanism by which caffeine protects against skin cancer is unknown. Ataxia telangiectasia and Rad3-related (ATR) is a replication checkpoint kinase activated by DNA stresses and is one of several targets of caffeine. Suppression of ATR, or its downstream target checkpoint kinase 1 (Chk1), selectively sensitizes DNA-damaged and malignant cells to apoptosis. Agents that target this pathway are currently in clinical trials. Conversely, inhibition of other DNA damage response pathways, such as ataxia telangiectasia mutated (ATM) and BRCA1, promotes cancer. To determine the effect of replication checkpoint inhibition on carcinogenesis, we generated transgenic mice with diminished ATR function in skin and crossed them into a UV-sensitive background, Xpc(-/-). Unlike caffeine, this genetic approach was selective and had no effect on ATM activation. These transgenic mice were viable and showed no histological abnormalities in skin. Primary keratinocytes from these mice had diminished UV-induced Chk1 phosphorylation and twofold augmentation of apoptosis after UV exposure (P = 0.006). With chronic UV treatment, transgenic mice remained tumor-free for significantly longer (P = 0.003) and had 69% fewer tumors at the end of observation of the full cohort (P = 0.019), compared with littermate controls with the same genetic background. This study suggests that inhibition of replication checkpoint function can suppress skin carcinogenesis and supports ATR inhibition as the relevant mechanism for the protective effect of caffeinated beverage intake in human epidemiologic studies.

Indexed as

AnimalsApoptosisAtaxia Telangiectasia Mutated ProteinsCaffeineCell Cycle ProteinsCheckpoint Kinase 1KeratinocytesMiceMice, TransgenicProtein KinasesProtein Serine-Threonine KinasesSkin NeoplasmsUltraviolet RaysAtaxia Telangiectasia Mutated ProteinsAtr protein, mouseCaffeineCell Cycle ProteinsCheckpoint Kinase 1CHEK1 protein, humanChek1 protein, mouseProtein KinasesProtein Serine-Threonine Kinases

Identifiers

PMID21844338
PMCPMC3158235
OpenAlexW2095557065

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.